// App-Quantinova.ai

P405 : INHIBITION OF CKS1-DEPENDENT PROTEOSTASIS REVEALS VULNERABILITIES IN LEUKAEMIC STEM CELLS WITH CONCOMITANT PROTECTION OF HEALTHY HAEMATOPOIETIC STEM CELLS

Researchers

Presenter

  • William Grey

Principal Investigators

  • Ana Rio-Machin

  • Pedro Casado-Izquierdo

  • Sara Ali

  • Juho Miettinen

  • Alun Parsons

  • Caroline Heckman

  • Charles Swanton

  • Pedro Cutillas

  • John Gribben

  • Jude Fitzgibbon

  • Dominique Bonnet

Medical Centers

  • HiLIFE,Helsinki,芬兰

  • HiLIFE,Helsinki,Finnland

  • The Francis Crick Institute,London,Royaume-uni

  • Bart's Cancer Institute,London,Vereinigtes Königreich

  • The Francis Crick Institute,London,Regno Unito

  • HiLIFE,Helsinki,Finnland

  • Bart's Cancer Institute,London,Соединённое Королевство

  • Bart's Cancer Institute,London,Royaume-uni

  • The Francis Crick Institute,London,Regno Unito

  • HiLIFE,Helsinki,Finnland

  • Barts Cancer Institute,...

  • York Biomed

  • Bart's Cancer Institute, London, United Kingdom

  • The Francis Crick Institute,London,Соединённое Ко

  • Bart's Cancer Institute,London,Reino Unido

  • Bart's Cancer Institute,London,Reino Unido

  • The Francis Crick Institute, London, United Kingdom

  • Bart's Cancer Institute,London,Verenigd Koninkrijk

  • HiLIFE,Helsinki,Финляндия

  • The Francis Crick Institute,London,Vereinigtes Königreich

  • The Francis Crick Institute,London,Verenigd Koninkrijk

  • HiLIFE,Helsinki,Finnland

Locations

  • United States

  • United Kingdom

  • Finland

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A